novo semaglutide Nordisk withdraws FDA application to expand use of weight loss drug Novo Nordisk Settles Ozempic Patent

Any prescription-based option requires independent medical evaluation, screening, and approval through a licensed prescribing provider when appropriate

Here are this weeks picks and some further reading suggestions among the latest medical news

They also outline methods to prevent or delay type 2 diabetes and its related comorbidities, such as obesity, while offering care recommendations aimed at improving health outcomes

Lack of association between selenium status and disease severity and activity in patients with Graves ophthalmopathy

doi: 10.1016/S0021-9258(18)57335-X 27 MarkouKGeorgopoulosNKyriazopoulouVVagenakisAG